Found: 9
Select item for more details and to access through your institution.
A T cell receptor β chain–directed antibody fusion molecule activates and expands subsets of T cells to promote antitumor activity.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 724, p. 1, doi. 10.1126/scitranslmed.adi0258
- By:
- Publication type:
- Article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 7, p. 1027, doi. 10.1038/s41416-021-01664-8
- By:
- Publication type:
- Article
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00263-7
- By:
- Publication type:
- Article
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.
- Published in:
- Nature Communications, 2017, v. 8, n. 6, p. 15901, doi. 10.1038/ncomms15901
- By:
- Publication type:
- Article
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.
- Published in:
- Nature Communications, 2017, v. 8, n. 4, p. 14922, doi. 10.1038/ncomms14922
- By:
- Publication type:
- Article
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10501, doi. 10.1038/ncomms10501
- By:
- Publication type:
- Article
Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 329, p. 1, doi. 10.1126/scitranslmed.aad5653
- By:
- Publication type:
- Article
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 27, doi. 10.1002/1878-0261.12673
- By:
- Publication type:
- Article